4Mary C. Proctor: Indication for Filter Placement[J].Semin Vasc Surg, 2000, 13(3):194-198.
5Grassi CJ. Inferior vena caval filter: Analysis of five currently available devices[J].AJR Am J Roentgenol,1991, 156(4):813-821.
6Decousus H, Leizorovicz A, Parent F,et al. A clinical trial of vena caval filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis[J].N Engl J Med, 1998, 338(7):409-415.
7Girard P, Stern JB, Parent F. Medical literature and vena cava filters.So far so weak[J].Chest, 2002, 122(3):963-967.
8Streiff MB. Vena caval filters: a comprehensive review[J].Blood, 2000, 95(12):3669-3677.
9Grassi CJ, Swan TL, Cardella JF,et al. Quality improvement guidelines for percutaneous permanent inferior vena cava filter placement for the prevention of pulmonary embolism[J].J Vasc Interv Radiol, 2001, 12(2):137-141.
10Greenfield LJ, Proctor MC. Filter Complications and Their Management[J].Semin Vasc Surg, 2000, 13(3):213-216.
二级参考文献7
1Anderson FA Jr, Wheeler HB, Goldberg RJ, et al.A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study.Arch Intern Med,1991,151:933-938.
3Urokinase Pulmonary embolism trial: a national cooperative study. Circulation ,1973, 47:1-108.
4Goldhaber SZ, Kessler CM, Heit J, et al.Randomised controlled trial of recombinant tissue plasminogen activator versus urokinase in the treatment of acute pulmonary embolism.Lancet,1988,2:293-298.
5Goldhaber SZ. Evolving concepts in thrombolytic therapy for pulmonary embolism.Chest,1992,101(4 Suppl):183S-185S.
6Daniels LB, Parker JA, Patel SR, et al.Relation of duration of symptoms with response to thrombolytic therapy in pulmonary embolism.Am J Cardiol, 1997,80:184-188.
7Arcasoy SM, Kreit JW.Thrombolytic therapy of pulmonary embolism: a comprehensive review of current evidence.Chest,1999,115:1695-1707.
3PREPIC Study Group. Eight-year follow-up of patients with permanent vena cava filters in the prevention of pulmonary embolism: the PREPIC (Prevention du Risque d'Embolie Pulmonaire par Interruption Cave) randomized study [J]. Circulation ,2005,112(3) :416-422.
4Katsamouris AA, Waltman AC, Delichatsios MA, et al . Inferior vena cava filters: in vitro comparison of clot trapping and flow dynamics[J]. Radiology , 1988,166(2) : 361-366.
5Rogers FB, Strindberg G, Shackford SR, et al . Five-year follow-up of prophylactic vena cava filters in high-risk trauma patients[J]. Arch Surg ,1998, 133(4) : 406-411.
6Joels CS, Sing RF, Heniford BT. Complications of inferior vena eava filters[J]. Am Surg ,2003, 69(8):654-659.
7Decousus H, Leizorovicz A, Parent F, et al. A clinical trial of venacaval filters in the prevention of pulmonary embolism in patients with proximal deep vein thrombosis[J]. N Eng J Med,1998,338:409-415.
8Girard P, Tardy B, Decousus H, et al. Inferior vena cava interruption: how and when[J]. Annu Rev Med, 2000,51:12-15.
